<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03771768</url>
  </required_header>
  <id_info>
    <org_study_id>3:5:1</org_study_id>
    <nct_id>NCT03771768</nct_id>
  </id_info>
  <brief_title>Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease</brief_title>
  <acronym>BD</acronym>
  <official_title>Active Control,Randomized,Double- Blinded Clinical Trial of BD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laser therapy is increasingly showing promising results in dental field including oral
      ulcers.This trial will assess the usefulness of Diode Laser compared to corticosteroid on
      oral ulcers of patients diagnosed with Behcet's disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The enrolled patients will be divided randomly into two groups.one group will receive Diode
      Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and
      other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide
      0.1% 5 gram adhesive paste - Dermaphor) four times daily.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 25, 2019</start_date>
  <completion_date type="Anticipated">May 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
    <masking_description>Double - blinded trial:
Outcome assessor (CS) and Statistician. Participants couldn't be blinded because of the difference in the nature of interventions method of application.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Oral ulcer activity index</measure>
    <time_frame>One month</time_frame>
    <description>Composite index score (0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral health - related quality of life</measure>
    <time_frame>One month</time_frame>
    <description>Oral health impact profile - 14 (OHIP- 14)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain associated with oral ulcer</measure>
    <time_frame>One month</time_frame>
    <description>Visual analogue scale (0-10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Autoimmune</condition>
  <condition>Behcet Syndrome</condition>
  <arm_group>
    <arm_group_label>Triamcinolone acetonide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Triamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1 month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diode laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diode laser 980 nm &amp; 100mWatt.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Diode laser 980nm&amp;100 mWatt</intervention_name>
    <description>Diode laser 980 nm &amp;100 milli Watt.</description>
    <arm_group_label>Diode laser</arm_group_label>
    <other_name>Low level laser</other_name>
    <other_name>Biostimulation</other_name>
    <other_name>Soft laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide</intervention_name>
    <description>0.1 &amp;5gm paste 4 times/day</description>
    <arm_group_label>Triamcinolone acetonide</arm_group_label>
    <other_name>Topical corticosteroid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients diagnosed with Behcet's Disease according to International Criteria for BD.

          -  patients with active oral ulcers.

          -  patients free from any visible oral lesions other than the oral ulcers of BD.

          -  patients who agreed to take the supplied interventions.

          -  patients who will agree to participate in the study.

          -  patients who will accept to sign the informed consent.

        Exclusion Criteria:

          -  patients not physically able to participate in survey or clinical oral examination.

          -  patients with organ or life-threatening disease.

          -  patients with history of a severe or chronic medical condition including tuberculosis,
             hepatitis and human immunodeficiency virus.

          -  patients under immunosuppressive drugs.

          -  patients with organ transplantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sherin Ali Hassan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clair Sobhy Nagieb, MSC</last_name>
    <phone>01222259819</phone>
    <phone_ext>Cairo U</phone_ext>
    <email>Clair.nadieb@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zaki S.Zaki, MSC</last_name>
    <phone>01224045116</phone>
    <email>drzaki95@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Prasad R S, Pai A. Assessment of immediate pain relief with laser treatment in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Aug;116(2):189-93. doi: 10.1016/j.oooo.2013.02.011. Epub 2013 Apr 23.</citation>
    <PMID>23622766</PMID>
  </reference>
  <reference>
    <citation>Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici H. Outcome measures used in clinical trials for Beh√ßet syndrome: a systematic review. J Rheumatol. 2014 Mar;41(3):599-612. doi: 10.3899/jrheum.131249. Epub 2014 Feb 1. Review.</citation>
    <PMID>24488418</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 1, 2018</study_first_submitted>
  <study_first_submitted_qc>December 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2018</study_first_posted>
  <last_update_submitted>April 8, 2019</last_update_submitted>
  <last_update_submitted_qc>April 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Clair Sobhy Nagieb Botros</investigator_full_name>
    <investigator_title>Principal invistigator</investigator_title>
  </responsible_party>
  <keyword>Oral ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behcet Syndrome</mesh_term>
    <mesh_term>Oral Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

